Cannin’s top 3 cannabis stock gainers surged as much as 50% today – but what cannabis stocks were they?
In fact, Cannin’s CanninBot software detected these huge potential gains late last night and our members were notified about these opportunities. Keep reading to learn about companies behind the top 3 cannabis stock gainers are for today.
Related: Little-known Biotech Stock Up 149%
Today’s Top Cannabis Stock Gainer #1: Rising Biosciences (RBII) – Up 50%
Rising Biosciences, Inc. operates as a research and development company. The Company focuses on oral and topical pharmaceutical products for liver and brain damage treatment, medications, and therapies. Rising Biosciences offers its services throughout the United States.
Today’s Top Cannabis Stock Gainer #2: Grow Solutions Holdings, Inc. (GRSO) – Up 36%
Second on our top gainers for the day is Grow Solutions Holdings, Inc., formerly LightTouch Vein & Laser, Inc., which provides indoor and outdoor gardening supplies to the garden industry. The Company provides products and services to the regulated legal cannabis industry. The Company is focused on providing services within the legal cannabis industry to those growing, processing and dispensing legal cannabis and legal cannabis-related products.
The Company also delivers consulting services that include design and construction to approved and licensed legal cannabis operators, as well as assistance with licensure and related applications for potential legal cannabis operators. One Love Garden Supply LLC (OneLove) is a subsidiary of the Company. OneLove provides indoor and outdoor gardening supplies for all gardening needs. OneLove has a selection of plant nutrients in the Boulder, Colorado area. OneLove also carries in store grow room building supplies and indoor gardening equipment. OneLove provides grow room design consultants.
Today’s Top Cannabis Stock Gainer #3: Cure Pharmaceutical Holdings (CURR) – Up 25%
CURE Pharmaceutical Holding Corp., together with its subsidiaries, operates as a technology focused vertically integrated drug delivery and product development company in the pharmaceutical, and health and wellness markets. It focuses on the development and manufacturing of drug formulation and drug delivery technologies in novel dosage forms to enhance drug safety, efficacy, and patient adherence. The company operates through two business segments: Cure and Sera Labs.
Related: Cure Pharmaceutical Holding Corp
Its pharmaceutical drug programs include CUREfilm Blue, a sildenafil oral thin film (OTF) for the treatment of erectile dysfunction; cannabinoid products with optimized pharmacokinetic profiles using microCURE and CUREfilm technology; CUREfilm Anti-Viral, an orally bio-available anti-viral of an existing therapeutic leveraging existing pre-clinical/clinical safety and toxicity data; and CUREfilm Central Nervous System, a novel dosage form to treat mental health disorders, such as depression, PTSD, addiction disorders, obsessive compulsive disorders, and anxiety. The company also sells various wellness products under its distribution partners’ brands. In addition, it is developing 50,000IU and Vitamin D3 OTF for oral administration. The company has a licensing agreement with Canopy Growth Corporation. CURE Pharmaceutical Holding Corp. was founded in 2011 and is based in Oxnard, California.
How did CanninBot Identify these Cannabis Stock Trade Opportunities?
CanninBot uses the power of several proprietary machine learning algorithms to evaluate 450 cannabis stocks based on the 10 best technical indicators.
Related: Little-known Cannabis Beverage Stock Surges 47%
From this data, our subscribers receive a daily CanninBot score with the top 20 cannabis stocks for that specific day. In fact, most all of our CanninBot stocks have made great gains for the day:
Sign up for your free week now and you’ll receive daily alerts with a ranking for the 20 strongest stocks, for that specific day, allowing you the best opportunity to make serious potential gains like 281% our members made on NSHSF today.
Related: Up Over 80% this Week – Is Core One Labs a Buy?
Who are the Experts Behind Cannin.com?
Since 2017, Cannin.com has been on a mission to help our members profit from investing in cannabis stocks. Cannin’s global team provides the tools and information for our members to capitalize on this rapidly growing industry.
Related: Hemp Stock Quotes | Marijuana Stock Quotes
In fact, 78% of Cannin’s fundamentals prove true within 30 days or less on 100+ recommendations over the last 3 years.
Cannin’s Top 3 Cannabis Stock Gainers Today
About Cannin: Your Cannabis Stocks Resource
78% of Cannin’s fundamentals prove true within 30 days or less on 100+ recommendations over the past 2 years.
Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. We aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2021.
Use Cannin as your resource for:
Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.
Are you looking to buy stock in hemp companies or marijuana companies for 2021? Interested in new penny hemp stock companies? Looking for the best Canadian cannabis stocks to invest in? Looking to leverage the power of algorithmic stock trading to beat the cannabis market? We can help.
Are you interested in cannabis stocks like Curaleaf, Trulieve, Aurora Cannabis, Charlotte’s Web, Canopy Growth, or Hemp Inc.?
Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.
- +30% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
We’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best cannabis stocks – we’ll show you how at cannin.com.
